Oral mTOR Inhibition Limits And Reduces Actinic Keratosis And Cutaneous Squamous Cell Carcinoma In A UVB-Induced Mouse Model
M. G. Booty, B. Komalo, A. Hosny, S. E. Headland, M.-T. Fernandez-Figueras, A. M. Nguyen, W. Cousin, J. Heinrich, L. Nicolaisen, R. M. DeVay, B. White, c. elabd
This study shows oral mTOR inhibitors reduce actinic keratosis and cutaneous squamous cell carcinoma in a UVB-induced mouse model by limiting lesion size and frequency.
bioRxiv · Nov 3, 2022 · PreprintPharmacology & Toxicology